Check Out What Whales Are Doing With TMO
read more ​ ​read moreÂ
Media
Blood Cancer-Focused Blueprint Medicines Could Be ‘Attractive Target For Partnerships’: Analyst
- by
- November 15, 2024
JP Morgan initiates coverage on Blueprint Medicines, highlighting Ayvakit’s significant growth, 2024 revenue forecast, and potential strategic opportunities. Latest Ratings for BPMC Date Firm Action From To Mar 2022 Stifel Maintains Buy Mar 2022 Citigroup Initiates Coverage On Neutral Feb 2022 SVB Leerink Downgrades Outperform Market Perform View More Analyst Ratings for BPMC View the
Media
Elon Musk’s Hedgehog Meme Coin ‘SHRUB’ Outpaces Dogecoin, Shiba Inu Gains, Surges 3,000% In A Week
- by
- November 15, 2024
Shrub (CRYPTO: SHRUB), the new pet of Elon Musk‘s family, is trading more than 3,300% higher in seven days as whales keep accumulating the meme coin following read more ​ ​Shrub (CRYPTO: SHRUB), the new pet of Elon Musk‘s family, is trading more than 3,300% higher in seven days as whales keep accumulating the meme
Media
UnitedHealth’s Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape
- by
- November 15, 2024
An aging U.S. population is increasing demand for home health care. The Optum-Amedisys merger, with divestitures to VitalCaring, aims to balance growth and competition. read more ​ ​An aging U.S. population is increasing demand for home health care. The Optum-Amedisys merger, with divestitures to VitalCaring, aims to balance growth and competition. read moreÂ
Media
How Is The Market Feeling About Atmos Energy?
- by
- November 15, 2024
read more ​ ​read moreÂ
Media
2 High-Yield Midstream Stocks to Buy Hand Over Fist and 1 to Avoid
- by
- November 14, 2024
​Post Content  Read More
Media
Chipotle shareholder sues company after portion sizes go viral
- by
- November 14, 2024
A Chipotle shareholder is suing the company, claiming they faced “significant losses” due to the alleged portion-size reductions that caused a frenzy over social media. On Monday, a proposed class-action lawsuit was filed on behalf of Micheal Stradford, who claimed that the company had “understated how difficult it would be to compete” within the highly